f057910-6ad6-5fd3-8440-9eda32b67c1d

Property	Value
?:author	claimskg:creative_work_author/5ba994ed-d774-588c-a98c-0e86b15c12e4
?:citation	<https://archive.is/8QJs3?> <https://archive.is/Lzmyg?> <https://archive.is/cl4CT?> <https://archive.is/na11v?> <https://archive.is/uForX?> <https://perma.cc/863K-C4VB?> <https://perma.cc/8KJH-QXXX?> <https://perma.cc/BP5K-LGUM?> <https://perma.cc/C5B3-M46A?> <https://perma.cc/HE99-DVXX?> <https://perma.cc/M3XN-ZDHC?> <https://perma.cc/P586-WT6S?> <https://perma.cc/PL9R-FME2?> <https://perma.cc/U6FH-XKWQ?> <https://web.archive.org/web/20220131083026/https://www.reuters.com/business/healthcare-pharmaceuticals/japans-kowa-says-ivermectin-effective-against-omicron-phase-iii-trial-2022-01-31/?> <https://www.npr.org/sections/health-shots/2021/09/19/1038369557/ivermectin-anti-vaccine-movement-culture-war?>
?:datePublished	2022-01-31 (xsd:date)
is ?:itemReviewed of	claimskg:claim_review/d5045a86-105c-5cc9-b1f7-18a6ae1738c9
?:keywords	claimskg:keyword/9a6224c1-a608-5ae5-b667-237ea3dedb51
?:mentions	claimskg:mention/2ac243d2-f8bd-502a-8c61-02c9d4bb01fb claimskg:mention/582168f4-8cd9-516c-ba20-5f65cd669a2a claimskg:mention/ed24cf93-bf52-5831-874c-2c0577ca0597 claimskg:mention/fbf1c302-964d-5820-a07c-b29f8d751f27 claimskg:mention/fe99a9d0-2d6b-5804-8f56-5e117925ec94
?:text	Japan's Kowa says ivermectin effective against Omicron in phase III trial (en)
rdf:type	<http://schema.org/CreativeWork>